Insider Cluster (2 insiders) ·Filed Aug 10, 2026

ELAN

Elanco Animal Health Inc
NEUTRAL
Impact 3/10
Horizonweeks Processed1mo ago
Insider cluster: 2 insiders, $334K total
Actionable Insight • Neutral

The insider buying is too small to be a standalone signal, but it reinforces the positive post-earnings sentiment. Monitor for larger insider purchases in the coming weeks to confirm conviction. The raised guidance and accelerating innovation adoption (Zenrelia, Credelio Quattro) provide fundamental support.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d ⚠ clustered
ELAN ▲ +3.61% at T+20d
NEUTRAL call ✓ call won +3.61% · α vs SPY +4.67% · entry $22.73 → $23.55
Next anchor: T+60d in 5w
Latest observation: T+34 +11.57% FF3 residual α
Entry anchored
Aug 10, 04:14 PM ET
via 1-min bar
T+1d
-2.64%
call -2.64% · α -2.89%
$22.13
settled 7w ago
T+5d
+4.00%
call +4.00% · α +4.41%
$23.64
settled 7w ago
T+20d
+3.61%
call +3.61% · α +4.67%
$23.55
settled 24d ago
T+60d
—
call — · α —
—
in 5w

Price Chart

Loading chart...

Executive Summary

Two Elanco insiders (Director Herendeen and CFO VanHimbergen) made open-market purchases totaling $334K in the week following a strong Q2 earnings beat-and-raise. While the dollar amount is trivial relative to Elanco's $11.1B market cap (0.003%), the timing after positive results and the CFO's participation add modest credibility to the bullish earnings signal.

Key Financial Metrics

Direction
buying
Total Value
$333.8K
Insiders
2

Key Facts

  • Director Paul Herendeen purchased 10,000 shares at $23.68 for $236,850 on 2026-08-07.
  • CFO Robert VanHimbergen purchased 4,200 shares at $23.08 for $96,926 on 2026-08-07.
  • Total open-market buying: $333,776, representing ~0.003% of Elanco's $11.1B market cap.
  • Purchases occurred 2 days after Elanco reported Q2 2026 adjusted EPS of $0.34 (26.5% beat) and raised full-year guidance.
  • Three other insiders received non-cash stock grants (no economic value) on the same date.

Financial Impact

Insider buying of $334K is immaterial relative to $11.1B market cap.

Risk Factors

  • Insider buying amount is negligible relative to market cap, limiting signal strength.
  • Only two insiders participated; broader C-suite buying would be more meaningful.
  • Historical cluster signals on ELAN have been strong, but this cluster is unusually small.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (23 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ELAN-1786392963982
13 reports for ELAN
Performance horizon
78% Hit rate 7 of 9 directional calls best @ T+5▲ +15.03%May 19, 2026
Filters
Rows
Reports for ELAN — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
Press Release
BULLISH ★ 6/10
$23.17 $22.42▼ −3.24%▼ −3.02%$22.14 (−4.45%)
Aug 21, 2026
6w ago
Insider Cluster
BULLISH ★ 6/10
$23.97 $24.11▲ +0.58%▲ +0.11%$22.14 (−7.63%)
Aug 21, 2026
6w ago
Insider Cluster
BULLISH ★ 4/10
$23.97 $24.11▲ +0.58%▲ +0.11%$22.14 (−7.63%)
Aug 18, 2026
6w ago
Insider Cluster
BULLISH ★ 4/10
$23.63 $25.09▲ +6.19%▲ +6.39%$22.14 (−6.30%)
Aug 13, 2026
7w ago
Insider Cluster
BULLISH ★ 4/10
$22.51 $23.56▲ +4.66%▲ +6.63%$22.14 (−1.64%)
Aug 10, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$22.73 $23.64▲ +4.00%▲ +4.41%$22.14 (−2.60%)
Aug 5, 2026
8w ago
8-K
BULLISH ★ 7/10
$26.22 $22.04▼ −15.95%▼ −16.30%$22.14 (−15.56%)
Jun 29, 2026
13w ago
Court Ruling
NEUTRAL ★ 2/10
$24.74 $25.13▲ +1.58%▲ +0.19%$22.14 (−10.51%)
May 19, 2026
19w ago
Insider Cluster
NEUTRAL ★ 3/10
$23.61 $24.58▲ +4.11%▲ +3.64%$22.14 (−6.22%)
May 19, 2026
19w ago
Insider Cluster
BULLISH ★ 4/10
$20.83 $23.69▲ +13.74%▲ +12.50%$22.14 (+6.30%)
Showing 10 of 13

US Market Status

Market Closed — Opens Mon (64h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 10, 2026